Overview
Announcements

Ordinary Rebalance | Solactive Global Vaccines and Infectious Diseases Index | Effective Date 15th August 2023

In the ordinary rebalance, the following index composition will be implemented effective open 15.08.2023:

3SBIO INC
WUXI BIOLOGICS CAYMAN INC
SK BIOSCIENCE ORD
SHIONOGI & CO LTD ORD
ABBOTT LABORATORIES
ADAPTIVE BIOTECHNOLOGIES CORP
ASTRAZENECA PLC
BAVARIAN NORDIC A/S
BIONTECH SE
CATALENT INC
CUREVAC BV
DYNAVAX TECHNOLOGIES CORP
GILEAD SCIENCES INC
GENMAB A/S
GSK PLC
IMMUNITYBIO INC
JOHNSON & JOHNSON
LABORATORY CRP OF AMER HLDGS
ELI LILLY & CO
MERCK & CO. INC.
MODERNA INC
MARAVAI LIFESCIENCES HOLDINGS INC
OPKO HEALTH INC
VAXCYTE INC
PFIZER INC
REGENERON PHARMACEUTICALS
SANOFI SA
VIR BIOTECHNOLOGY INC
VALNEVA SE
ZOETIS INC